Soros Fund Management LLC Has $23.05 Million Stake in Sanofi (NASDAQ:SNY)

Soros Fund Management LLC raised its stake in shares of Sanofi (NASDAQ:SNY) by 166.7% during the third quarter, Holdings Channel reports. The firm owned 400,000 shares of the company’s stock after buying an additional 250,000 shares during the period. Soros Fund Management LLC’s holdings in Sanofi were worth $23,052,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Northwest Investment Counselors LLC acquired a new position in Sanofi during the 3rd quarter worth $29,000. POM Investment Strategies LLC bought a new position in shares of Sanofi in the 2nd quarter valued at about $25,000. Concord Wealth Partners raised its position in shares of Sanofi by 157.8% during the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after acquiring an additional 363 shares during the last quarter. Arrow Financial Corp bought a new position in shares of Sanofi in the 2nd quarter worth $35,000. Finally, Fortitude Family Office LLC increased its holdings in Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after purchasing an additional 659 shares during the last quarter. 10.04% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

SNY has been the topic of several research analyst reports. Citigroup raised Sanofi to a “strong-buy” rating in a research note on Tuesday, September 17th. StockNews.com downgraded Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th. One research analyst has rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $57.50.

Sanofi Trading Up 1.0 %

Shares of NASDAQ:SNY opened at $48.51 on Friday. The stock has a market cap of $123.11 billion, a PE ratio of 24.75, a P/E/G ratio of 1.22 and a beta of 0.58. The business has a 50 day moving average of $52.25 and a 200-day moving average of $52.11. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. Sanofi has a 12-month low of $45.22 and a 12-month high of $58.97.

Sanofi (NASDAQ:SNY) last announced its earnings results on Friday, October 25th. The company reported $1.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $1.35. The company had revenue of $13.44 billion during the quarter, compared to analysts’ expectations of $16.59 billion. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. Sanofi’s quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.55 earnings per share. As a group, equities research analysts forecast that Sanofi will post 4.28 earnings per share for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.